Logo image of CML.MI

COMAL SPA (CML.MI) Stock Fundamental Analysis

BIT:CML - Euronext Milan - IT0005428971 - Common Stock - Currency: EUR

5.08  0 (0%)

Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to CML. CML was compared to 54 industry peers in the Electrical Equipment industry. While CML belongs to the best of the industry regarding profitability, there are concerns on its financial health. CML is not overvalued while it is showing excellent growth. This is an interesting combination.


Dividend Valuation Growth Profitability Health

Quickly go to:

8

1. Profitability

1.1 Basic Checks

In the past year CML was profitable.
CML had a negative operating cash flow in the past year.
CML had positive earnings in each of the past 5 years.
In the past 5 years CML reported 4 times negative operating cash flow.
CML.MI Yearly Net Income VS EBIT VS OCF VS FCFCML.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 0 5M -5M -10M

1.2 Ratios

Looking at the Return On Assets, with a value of 1.83%, CML is in line with its industry, outperforming 59.62% of the companies in the same industry.
The Return On Equity of CML (20.81%) is better than 90.38% of its industry peers.
Looking at the Return On Invested Capital, with a value of 14.56%, CML belongs to the top of the industry, outperforming 94.23% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for CML is above the industry average of 8.11%.
The last Return On Invested Capital (14.56%) for CML is above the 3 year average (10.49%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 1.83%
ROE 20.81%
ROIC 14.56%
ROA(3y)2.62%
ROA(5y)2.89%
ROE(3y)17.19%
ROE(5y)19.48%
ROIC(3y)10.49%
ROIC(5y)12.54%
CML.MI Yearly ROA, ROE, ROICCML.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 10 20 30

1.3 Margins

The Profit Margin of CML (6.97%) is better than 86.54% of its industry peers.
In the last couple of years the Profit Margin of CML has grown nicely.
With an excellent Operating Margin value of 14.12%, CML belongs to the best of the industry, outperforming 90.38% of the companies in the same industry.
CML's Operating Margin has improved in the last couple of years.
CML has a better Gross Margin (44.47%) than 65.38% of its industry peers.
CML's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 14.12%
PM (TTM) 6.97%
GM 44.47%
OM growth 3Y5.5%
OM growth 5Y21.44%
PM growth 3Y7.89%
PM growth 5Y26.25%
GM growth 3Y9.58%
GM growth 5Y17.09%
CML.MI Yearly Profit, Operating, Gross MarginsCML.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 10 20 30 40

More info and screens

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so CML is creating value.
CML has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, CML has more shares outstanding
Compared to 1 year ago, CML has an improved debt to assets ratio.
CML.MI Yearly Shares OutstandingCML.MI Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M
CML.MI Yearly Total Debt VS Total AssetsCML.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M

2.2 Solvency

CML has an Altman-Z score of 0.75. This is a bad value and indicates that CML is not financially healthy and even has some risk of bankruptcy.
CML has a Altman-Z score of 0.75. This is in the lower half of the industry: CML underperforms 69.23% of its industry peers.
A Debt/Equity ratio of 0.67 indicates that CML is somewhat dependend on debt financing.
CML has a Debt to Equity ratio (0.67) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.67
Debt/FCF N/A
Altman-Z 0.75
ROIC/WACC2.02
WACC7.2%
CML.MI Yearly LT Debt VS Equity VS FCFCML.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 0 10M -10M

2.3 Liquidity

CML has a Current Ratio of 1.11. This is a normal value and indicates that CML is financially healthy and should not expect problems in meeting its short term obligations.
CML has a worse Current ratio (1.11) than 71.15% of its industry peers.
CML has a Quick Ratio of 1.11. This is a bad value and indicates that CML is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.36, CML is doing worse than 96.15% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.11
Quick Ratio 0.36
CML.MI Yearly Current Assets VS Current LiabilitesCML.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M

More info and screens

9

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 22.54% over the past year.
The Earnings Per Share has been growing by 55.98% on average over the past years. This is a very strong growth
Looking at the last year, CML shows a decrease in Revenue. The Revenue has decreased by -3.02% in the last year.
Measured over the past years, CML shows a very strong growth in Revenue. The Revenue has been growing by 23.83% on average per year.
EPS 1Y (TTM)22.54%
EPS 3Y51.97%
EPS 5Y55.98%
EPS Q2Q%-0.7%
Revenue 1Y (TTM)-3.02%
Revenue growth 3Y41.46%
Revenue growth 5Y23.83%
Sales Q2Q%-13.6%

3.2 Future

CML is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 21.72% yearly.
CML is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 35.30% yearly.
EPS Next Y13.96%
EPS Next 2Y21.72%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year99.15%
Revenue Next 2Y51.57%
Revenue Next 3Y54.8%
Revenue Next 5Y35.3%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CML.MI Yearly Revenue VS EstimatesCML.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M
CML.MI Yearly EPS VS EstimatesCML.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 0.1 0.2 0.3 0.4 0.5

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 14.51 indicates a correct valuation of CML.
Based on the Price/Earnings ratio, CML is valued cheaper than 80.77% of the companies in the same industry.
CML is valuated rather cheaply when we compare the Price/Earnings ratio to 27.45, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 12.57 indicates a correct valuation of CML.
75.00% of the companies in the same industry are more expensive than CML, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 21.90. CML is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 14.51
Fwd PE 12.57
CML.MI Price Earnings VS Forward Price EarningsCML.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CML is valued a bit cheaper than the industry average as 67.31% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 9.21
CML.MI Per share dataCML.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

CML's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The excellent profitability rating of CML may justify a higher PE ratio.
A more expensive valuation may be justified as CML's earnings are expected to grow with 21.72% in the coming years.
PEG (NY)1.04
PEG (5Y)0.26
EPS Next 2Y21.72%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CML!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

COMAL SPA

BIT:CML (3/17/2025, 7:00:00 PM)

5.08

0 (0%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners5.11%
Inst Owner ChangeN/A
Ins Owners15.28%
Ins Owner ChangeN/A
Market Cap66.50M
Analysts80
Price Target5.81 (14.37%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 14.51
Fwd PE 12.57
P/S 1.12
P/FCF N/A
P/OCF N/A
P/B 3.35
P/tB 3.98
EV/EBITDA 9.21
EPS(TTM)0.35
EY6.89%
EPS(NY)0.4
Fwd EY7.95%
FCF(TTM)-0.84
FCFYN/A
OCF(TTM)-0.51
OCFYN/A
SpS4.53
BVpS1.52
TBVpS1.28
PEG (NY)1.04
PEG (5Y)0.26
Profitability
Industry RankSector Rank
ROA 1.83%
ROE 20.81%
ROCE 23.62%
ROIC 14.56%
ROICexc 27.65%
ROICexgc 32.88%
OM 14.12%
PM (TTM) 6.97%
GM 44.47%
FCFM N/A
ROA(3y)2.62%
ROA(5y)2.89%
ROE(3y)17.19%
ROE(5y)19.48%
ROIC(3y)10.49%
ROIC(5y)12.54%
ROICexc(3y)16.97%
ROICexc(5y)17.84%
ROICexgc(3y)19.48%
ROICexgc(5y)20.06%
ROCE(3y)16.74%
ROCE(5y)19.7%
ROICexcg growth 3Y20.75%
ROICexcg growth 5Y17.56%
ROICexc growth 3Y20.8%
ROICexc growth 5Y14.05%
OM growth 3Y5.5%
OM growth 5Y21.44%
PM growth 3Y7.89%
PM growth 5Y26.25%
GM growth 3Y9.58%
GM growth 5Y17.09%
F-Score3
Asset Turnover0.26
Health
Industry RankSector Rank
Debt/Equity 0.67
Debt/FCF N/A
Debt/EBITDA 1.34
Cap/Depr 265.47%
Cap/Sales 7.33%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.11
Quick Ratio 0.36
Altman-Z 0.75
F-Score3
WACC7.2%
ROIC/WACC2.02
Cap/Depr(3y)308.58%
Cap/Depr(5y)270.84%
Cap/Sales(3y)7.68%
Cap/Sales(5y)6.74%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)22.54%
EPS 3Y51.97%
EPS 5Y55.98%
EPS Q2Q%-0.7%
EPS Next Y13.96%
EPS Next 2Y21.72%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-3.02%
Revenue growth 3Y41.46%
Revenue growth 5Y23.83%
Sales Q2Q%-13.6%
Revenue Next Year99.15%
Revenue Next 2Y51.57%
Revenue Next 3Y54.8%
Revenue Next 5Y35.3%
EBIT growth 1Y45.55%
EBIT growth 3Y49.24%
EBIT growth 5Y50.39%
EBIT Next Year81.84%
EBIT Next 3Y44.34%
EBIT Next 5Y31.71%
FCF growth 1Y23.73%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y45.82%
OCF growth 3YN/A
OCF growth 5YN/A